Calliditas Therapeutics AB (LTS:0A5R) 3-Year Book Growth Rate : -36.40% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Calliditas Therapeutics AB 3-Year Book Growth Rate?

Calliditas Therapeutics AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr2.24.

During the past 3 years, the average Book Value per Share Growth Rate was -36.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 9 years, the highest 3-Year average Book Value per Share Growth Rate of Calliditas Therapeutics AB was 301.20% per year. The lowest was -36.40% per year. And the median was 3.10% per year.

Competitive Comparison of Calliditas Therapeutics AB's 3-Year Book Growth Rate

For the Biotechnology subindustry, Calliditas Therapeutics AB's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calliditas Therapeutics AB's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calliditas Therapeutics AB's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Calliditas Therapeutics AB's 3-Year Book Growth Rate falls into.

Calliditas Therapeutics AB 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Calliditas Therapeutics AB (LTS:0A5R) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Calliditas Therapeutics AB 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Calliditas Therapeutics AB (LTS:0A5R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (LTS:0A5R) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

CALT:USA CALTX:Sweden CALTXs:UK LC8:Germany

Address

Kungsbron 1, D5, Stockholm, SWE, SE-111 22

Website

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.

Calliditas Therapeutics AB (LTS:0A5R) Headlines

No Headlines